|
1
|
Roger VL, Go AS, Lloyd-Jones DM, Benjamin
EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al:
Heart disease and stroke statistics-2012 update: A report from the
American Heart Association. Circulation. 125:e2–e220. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Opie LH, Commerford PJ, Gersh BJ and
Pfeffer MA: Controversies in ventricular remodelling. Lancet.
367:356–367. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Biomarkers, genomics, telemetry,
computational biology and zebrafish: Will one of these solve the
problems of post-myocardial infarction heart failure? Eur Heart J.
35:57–58. 2014.PubMed/NCBI
|
|
4
|
Khan R and Sheppard R: Fibrosis in heart
disease: Understanding the role of transforming growth factor-beta
in cardiomyopathy, valvular disease and arrhythmia. Immunology.
118:10–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mann DL: Mechanisms and models in heart
failure: A combinatorial approach. Circulation. 100:999–1008. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fosshaug LE, Berge RK, Beitnes JO, Berge
K, Vik H, Aukrust P, Gullestad L, Vinge LE and Øie E: Krill oil
attenuates left ventricular dilatation after myocardial infarction
in rats. Lipids Health Dis. 10:2452011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang F, Yang XP, Liu YH, Xu J, Cingolani
O, Rhaleb NE and Carretero OA: Ac-SDKP reverses inflammation and
fibrosis in rats with heart failure after myocardial infarction.
Hypertension. 43:229–236. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jugdutt BI: Aging and remodeling during
healing of the wounded heart: Current therapies and novel drug
targets. Curr Drug Targets. 9:325–344. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nicoletti A, Heudes D, Mandet C, Hinglais
N, Bariety J and Michel JB: Inflammatory cells and myocardial
fibrosis: Spatial and temporal distribution in renovascular
hypertensive rats. Cardiovasc Res. 32:1096–1107. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bujak M and Frangogiannis NG: The role of
TGF-beta signaling in myocardial infarction and cardiac remodeling.
Cardiovasc Res. 74:184–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang H, Wu J, Dong H, Khan SA, Chu ML and
Tsuda T: Fibulin-2 deficiency attenuates angiotensin II-induced
cardiac hypertrophy by reducing transforming growth factor-β
signalling. Clin Sci (Lond). 126:275–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Muslin AJ: MAPK signalling in
cardiovascular health and disease: Molecular mechanisms and
therapeutic targets. Clin Sci (Lond). 115:203–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yeh CC, Li H, Malhotra D, Turcato S,
Nicholas S, Tu R, Zhu BQ, Cha J, Swigart PM, Myagmar BE, et al:
Distinctive ERK and p38 signaling in remote and infarcted
myocardium during post-MI remodeling in the mouse. J Cell Biochem.
109:1185–1191. 2010.PubMed/NCBI
|
|
14
|
Thum T, Gross C, Fiedler J, Fischer T,
Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et
al: MicroRNA-21 contributes to myocardial disease by stimulating
MAP kinase signalling in fibroblasts. Nature. 456:980–984. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krishnamurthy RG, Senut MC, Zemke D, Min
J, Frenkel MB, Greenberg EJ, Yu SW, Ahn N, Goudreau J, Kassab M, et
al: Asiatic acid, a pentacyclic triterpene from Centella
asiatica, is neuroprotective in a mouse model of focal cerebral
ischemia. J Neurosci Res. 87:2541–2550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang SS, Chiu CS, Chen HJ, Hou WC, Sheu
MJ, Lin YC, Shie PH and Huang GJ: Antinociceptive activities and
the mechanisms of anti-inflammation of asiatic acid in mice. Evid
Based Complement Alternat Med. 2011:8958572011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ramachandran V, Saravanan R and
Senthilraja P: Antidiabetic and antihyperlipidemic activity of
asiatic acid in diabetic rats, role of HMG CoA: In vivo and in
silico approaches. Phytomedicine. 21:225–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bian D, Zhang J, Wu X, Dou Y, Yang Y, Tan
Q, Xia Y, Gong Z and Dai Y: Asiatic acid isolated from Centella
asiatica inhibits TGF-β1-induced collagen expression in human
keloid fibroblasts via PPAR-γ activation. Int J Biol Sci.
9:1032–1042. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong MS, Jung SH, Kim HJ, Kim JR, Zhao LX,
Lee ES, Lee EJ, Yi JB, Lee N, Cho YB, et al: Structure-related
cytotoxicity and anti-hepatofibric effect of asiatic acid
derivatives in rat hepatic stellate cell-line, HSC-T6. Arch Pharm
Res. 27:512–517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang LX, He RH, Yang G, Tan JJ, Zhou L,
Meng XM, Huang XR and Lan HY: Asiatic acid inhibits liver fibrosis
by blocking TGF-beta/Smad signaling in vivo and in vitro. PLoS One.
7:e313502012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Si L, Xu J, Yi C, Xu X, Wang F, Gu W,
Zhang Y and Wang X: Asiatic acid attenuates cardiac hypertrophy by
blocking transforming growth factor-β1-mediated hypertrophic
signaling in vitro and in vivo. Int J Mol Med. 34:499–506.
2014.PubMed/NCBI
|
|
22
|
Chan CY, Mong MC, Liu WH, Huang CY and Yin
MC: Three pentacyclic triterpenes protect H9c2 cardiomyoblast cells
against high-glucose-induced injury. Free Radic Res. 48:402–411.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Orenstein TL, Parker TG, Butany JW,
Goodman JM, Dawood F, Wen WH, Wee L, Martino T, McLaughlin PR and
Liu PP: Favorable left ventricular remodeling following large
myocardial infarction by exercise training. Effect on ventricular
morphology and gene expression. J Clin Invest. 96:858–866. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bunbupha S, Pakdeechote P, Kukongviriyapan
U, Prachaney P and Kukongviriyapan V: Asiatic acid reduces blood
pressure by enhancing nitric oxide bioavailability with modulation
of eNOS and p47phox expression in L-NAME-induced hypertensive rats.
Phytother Res. 28:1506–1512. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee KY, Bae ON, Serfozo K, Hejabian S,
Moussa A, Reeves M, Rumbeiha W, Fitzgerald SD, Stein G, Baek SH, et
al: Asiatic acid attenuates infarct volume, mitochondrial
dysfunction, and matrix metalloproteinase-9 induction after focal
cerebral ischemia. Stroke. 43:1632–1638. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Araki S, Izumiya Y, Hanatani S, Rokutanda
T, Usuku H, Akasaki Y, Takeo T, Nakagata N, Walsh K and Ogawa H:
Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction
and remodeling after experimental myocardial infarction. Circ Heart
Fail. 5:116–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vahtola E, Louhelainen M, Merasto S,
Martonen E, Penttinen S, Aahos I, Kytö V, Virtanen I and Mervaala
E: Forkhead class O transcription factor 3a activation and Sirtuin1
overexpression in the hypertrophied myocardium of the diabetic
Goto-Kakizaki rat. J Hypertens. 26:334–344. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan Z, Zhao W, Zhang X, Wang B, Wang J,
Sun X, Liu X, Feng S, Yang B and Lu Y: Scutellarin alleviates
interstitial fibrosis and cardiac dysfunction of infarct rats by
inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2.
Br J Pharmacol. 162:688–700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu D, Wang H, Zhang J, Zhang X, Xin C,
Zhang F, Lee Y, Zhang L, Lian K, Yan W, et al: Irisin improves
endothelial function in type 2 diabetes through reducing
oxidative/nitrative stresses. J Mol Cell Cardiol. 87:138–147. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen P, Pang S, Yang N, Meng H, Liu J,
Zhou N, Zhang M, Xu Z, Gao W, Chen B, et al: Beneficial effects of
schisandrin B on the cardiac function in mice model of myocardial
infarction. PLoS One. 8:e794182013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okada H, Takemura G, Kosai K, Li Y,
Takahashi T, Esaki M, Yuge K, Miyata S, Maruyama R, Mikami A, et
al: Postinfarction gene therapy against transforming growth
factor-beta signal modulates infarct tissue dynamics and attenuates
left ventricular remodeling and heart failure. Circulation.
111:2430–2437. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kurrelmeyer K, Kalra D, Bozkurt B, Wang F,
Dibbs Z, Seta Y, Baumgarten G, Engle D, Sivasubramanian N and Mann
DL: Cardiac remodeling as a consequence and cause of progressive
heart failure. Clin Cardiol. 21:I14–I19. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hein S, Arnon E, Kostin S, Schönburg M,
Elsässer A, Polyakova V, Bauer EP, Klövekorn WP and Schaper J:
Progression from compensated hypertrophy to failure in the
pressure-overloaded human heart: Structural deterioration and
compensatory mechanisms. Circulation. 107:984–991. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
White HD and Braunwald E: Applying the
open artery theory: Use of predictive survival markers. Eur Heart
J. 19:1132–1139. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vanhoutte D, Schellings M, Pinto Y and
Heymans S: Relevance of matrix metalloproteinases and their
inhibitors after myocardial infarction: A temporal and spatial
window. Cardiovasc Res. 69:604–613. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ren J, Zhang S, Kovacs A, Wang Y and
Muslin AJ: Role of p38alpha MAPK in cardiac apoptosis and
remodeling after myocardial infarction. J Mol Cell Cardiol.
38:617–623. 2005. View Article : Google Scholar : PubMed/NCBI
|
